Shaun Bagai - 20 Mar 2026 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: RNXT
Reported as of: 20 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Mar 2026, 21:16:41 UTC
Prior SEC filing: 22 Dec 2025
Next SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Shaun Bagai

Key filing fact

Shaun Bagai filed Form 4 for RenovoRx, Inc. (RNXT) on 24 Mar 2026.

Key facts

This page summarizes Shaun Bagai's Form 4 filing for RenovoRx, Inc. (RNXT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Mar 2026, 21:16.

Change

Previous filing in this sequence was filed on 22 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001862613 Primary reporting owner

Bagai Shaun

Relationship: Chief Executive Officer, Director
Address: C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW
Signature: /s/ Shaun Bagai
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RNXT transaction

Common Stock

Purchase

Transaction value
Shares: +24,300
Change %: +8.4%
Price
Shares after: 313,357
Date: 20 Mar 2026
Ownership: The Bagai Family Trust
Footnotes: F1, F3

RNXT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50,983
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RNXT transaction Derivative

Warrants

Purchase

Transaction value
Shares: +12,150
Change %
Price
Shares after: 12,150
Date: 20 Mar 2026
Ownership: The Bagai Family Trust
Underlying class: Common Stock
Underlying amount: 12,150
Exercise price: $1.93
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The securities were purchased in a private placement on March 20, 2026 for an aggregate of $25,000.

Footnote F2

The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report.

Footnote F3

289,057 shares of common stock are held of record by The Bagai Family Trust and were previously reported as "directly" beneficially held by the Reporting Person.